SCHEMBL31377124

SCHEMBL31377124

Cn1cnc(/C=C/C(=O)OCc2ccccc2)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.56
AKR1B10 O60218 6/20 0.52
AKR1B1 P15121 6/20 0.52
CA12 O43570 2/20 0.52
CA4 P22748 2/20 0.52
CA6 P23280 2/20 0.52
CA5A P35218 2/20 0.52
CA7 P43166 2/20 0.52
CA9 Q16790 2/20 0.52
CA14 Q9ULX7 2/20 0.52
CA5B Q9Y2D0 2/20 0.52
HCAR2 Q8TDS4 1/20 0.51
HDAC1 Q13547 1/20 0.49
HDAC2 Q92769 1/20 0.49
TTR P02766 1/20 0.48
ALDH1A1 P00352 6/20 0.47
POLB P06746 1/20 0.47
MAOB P27338 2/20 0.40
EGFR P00533 1/20 0.40
ERBB2 P04626 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6015303 0.81 HDAC1 (0.46) LMNACA12CA7CA9CA14
SCHEMBL6015299 0.81 HDAC1 (0.46) LMNACA12CA7CA9CA14
SCHEMBL18734271 0.81 LMNA (0.57) LMNAAKR1B10AKR1B1CA12CA4
SCHEMBL18707081 0.81 LMNA (0.57) LMNAAKR1B10AKR1B1CA12CA4
SCHEMBL2154529 0.76 HDAC1 (0.52) CA12CA7CA9CA14HCAR2
SCHEMBL1310629 0.76 HDAC1 (0.52) CA12CA7CA9CA14HCAR2
SCHEMBL20647911 0.74 TDP1 (0.50) LMNAALDH1A1POLBMAOBRAB9A
SCHEMBL7757786 0.74 HDAC1 (0.52) LMNAHCAR2HDAC1HDAC2ALDH1A1
SCHEMBL13473879 0.74 LMNA (0.58) LMNAAKR1B10AKR1B1CA12CA4
SCHEMBL31377148 0.74 LMNA (0.58) LMNAAKR1B10AKR1B1CA12CA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025064683-A1 SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS Interdict Bio, Inc. (US) 2025-03-27 WO disclosed
US-20250091989-A1 SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS Interdict Bio, Inc. (US) 2025-03-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250091989-A1 SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS MYC, KRAS, NRAS LMNA 2869/4885AKR1B10 2056/4885AKR1B1 2799/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.